Cardinal Health, Inc. (NYSE:CAH) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Cardinal Health, Inc. (NYSE:CAH) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 9.01

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On December 5, 2018, the Board of Directors (the "Board") of Cardinal Health, Inc. (the "Company") elected J. Michael Losh to the Board, effective immediately, to serve until the 2019 annual meeting of shareholders and until his successor is elected and qualified. The Board also appointed Mr.Losh to serve as chair of the Audit Committee. Mr. Losh is the retired Chief Financial Officer of General Motors Corporation and serves on the boards of directors of several other leading public companies. He previously served on the Company's Board (from 1996 through the spin-off of CareFusion Corporation in 2009) and as the Company's interim Chief Financial Officer (from July 2004 through May 2005).

Mr. Losh will participate in the non-management director compensation arrangements described in the Company's proxy statement for its 2018 annual meeting of shareholders. Following the Board’s recently-approved change to these compensation arrangements to provide directors elected between annual meetings of shareholders a prorated initial grant of restricted share units (“RSUs”), Mr. Losh also will receive a prorated initial grant of $161,465 of RSUs, reflecting his dates of service. The Board has determined that Mr. Losh is independent under the standards of the New York Stock Exchange and the Company's Corporate Governance Guidelines and is an “audit committee financial expert” for purposes of the Securities and Exchange Commission rules.

Item 9.01. Regulation FD Disclosure.

The Company issued a news release on December 7, 2018 announcing the election of Mr. Losh to the Board, which is being furnished as Exhibit 99.1 to this Form 8-K.

Item 9.01.Financial Statements and Exhibits.

(d) Exhibits.


CARDINAL HEALTH INC Exhibit
EX-99.1 2 exhibit991news_release3.htm EXHIBIT 99.1 Exhibit Exhibit 99.1     Media:Ellen Barry Investors: Lisa Capodici (614) 553-3858  (614) 757-5035 ellen.barry@cardinalhealth.com  lisa.capodici@cardinalhealth.comCardinal Health Elects J. Michael Losh to its Board of Directors DUBLIN,…
To view the full exhibit click here

About Cardinal Health, Inc. (NYSE:CAH)

Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.

An ad to help with our costs